Tag: Lanxess
Lanxess: UBS confirms its price target
(CercleFinance.com) – UBS estimates that the outlook implies a moderate increase in 2024 EBITDA. The analyst remains neutral on the value with an unchanged target of E27, which represents an…
Lanxess: targets significantly lower profit in 2024
(CercleFinance.com) – The group’s turnover during the 2023 financial year amounted to 6.714 billion euros, down 17.0% compared to 8.088 billion euros for the year former. EBITDA before exceptional items…
Lanxess: UBS downgrades its recommendation
(CercleFinance.com) – UBS downgrades its recommendation on Lanxess from ‘buy’ to ‘neutral’ with a price target reduced from 48 to 30 euros, pointing to ‘limited visibility on organic deleveraging over…
Lanxess: Stifel lowers its price target
(CercleFinance.com) – Stifel maintains its ‘buy’ recommendation, but reduces its price target on the share price of the German specialty chemicals company Lanxess from 50 to 45 euros, due to…
LANXESS AG: Goldman Sachs confirms its neutral recommendation
Initially neutral on the file, Georgina Fraser of Goldman Sachs maintains her recommendation. The target price is unchanged at 40 EUR. Zonebourse…
Lanxess: new rebound after the release of HPM
(CercleFinance.com) – The stock continues to rise today (+3.3%) after yesterday’s gain of more than 11% following the announcement of HPM’s partial exit. The stock has gained almost 20% over…
LANXESS AG: DZ Bank favorable on the file
In a research note published by Peter Spengler, the broker DZ Bank advises to be interested in the title with a buying…
Lanxess: Credit Suisse remains positive, adjusts its target
(CercleFinance.com) – Credit Suisse maintains its ‘outperformance’ opinion on Lanxess, but lowers its price target from 67 to 58 euros, due to an 18% reduction on average in its 2022-24…
Lanxess: UBS reiterates advice after HPM exit
(CercleFinance.com) – The group has announced the partial exit from HPM. Following this announcement, UBS confirms its buying advice with a target of 59 E. “The partial exit of the…
DSM, Firmenich, Lanxess, the three-way operation in chemistry that seduces the markets
The two chemists Lanxess and DSM posted the two strongest increases in the Stoxx 600 index of the largest stocks listed in Europe. The first, German, will take over, with…
LANXESS AG: Jefferies reiterates its positive opinion on the stock
Already positive on the record, research at Jefferies and its analyst Chris Counihan still consider the title as a buying opportunity. The…
Ems is flirting with previous deals from Lanxess and Solvay
The chemical company Ems has increased sales by a quarter despite a still weak automotive market. The head of the company, Magdalena Martullo-Blocher, is concerned about the sharp rise in…